Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 68 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Sarafidis, Pantelis  [Clear All Filters]
Journal Article
Theodorakopoulou, M., Loutradis C., Bikos A., Angeloudi E., Schoina M., Raptis V., et al. (2020).  The Effects of Nebivolol and Irbesartan on Ambulatory Aortic Blood Pressure and Arterial Stiffness in Hemodialysis Patients with Intradialytic Hypertension.. Blood Purif. 1-11.
Gargani, L., Sicari R., Raciti M., Serasini L., Passera M., Torino C., et al. (2016).  Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project.. Nephrol Dial Transplant. 31(12), 1982-1988.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  Erratum.. Nephrol Dial Transplant. 35(8), 1452.
Sampani, E., Sarafidis P., & Papagianni A. (2020).  Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment.. Expert Opin Drug Saf. 19(6), 673-682.
Pappaccogli, M., Di Monaco S., Warchoł-Celińska E., Lorthioir A., Amar L., Aparicio L. S., et al. (2020).  THE EUROPEAN/INTERNATIONAL FIBROMUSCULAR DYSPLASIA REGISTRY AND INITIATIVE (FEIRI)- CLINICAL PHENOTYPES AND THEIR PREDICTORS BASED ON A COHORT OF ONE THOUSAND PATIENTS.. Cardiovasc Res.
Fernandez-Fernandez, B., D'Marco L., Gorriz J. Luis, Jacobs-Cachá C., Kanbay M., Luis-Lima S., et al. (2020).  Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19.. J Clin Med. 9(7), 
Chalkidou, M., Pella E., Hatzichristou D., & Sarafidis P. (2020).  Fractioned urine collections to assess urine supersaturation in urolithiasis; a pathway worth exploring.. Urolithiasis. 48(5), 465-466.
Ruiz-Hurtado, G., Sarafidis P., Fernández-Alfonso M. S., Waeber B., & Ruilope L. M. (2016).  Global cardiovascular protection in chronic kidney disease.. Nat Rev Cardiol. 13(10), 603-8.
Loutradis, C., Ferro C. J., & Sarafidis P. (2020).  Hypertension Management in Patients With Autosomal Dominant Polycystic Kidney Disease: Time for a Paradigm Shift?. Am J Kidney Dis. 76(5), 743.
Theodorakopoulou, M., Raptis V., Loutradis C., & Sarafidis P. (2019).  Hypoxia and Endothelial Dysfunction in Autosomal-Dominant Polycystic Kidney Disease.. Semin Nephrol. 39(6), 599-612.
Saratzis, A., Sarafidis P., Melas N., Saratzis N., & Kitas G. (2013).  Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair.. J Vasc Surg. 58(4), 879-85.
Torino, C., Gargani L., Sicari R., Letachowicz K., Ekart R., Fliser D., et al. (2020).  Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study.. J Nephrol. 33(3), 583-590.
Ferro, C. J., Mark P. B., Kanbay M., Sarafidis P., Heine G. H., Rossignol P., et al. (2018).  Lipid management in patients with chronic kidney disease.. Nat Rev Nephrol. 14(12), 727-749.
Ferro, C. J., Sarafidis P., & Ortiz A. (2020).  Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.. N Engl J Med. 382(21), e65.
Loutradis, C., Papadopoulos C. E., & Sarafidis P. (2020).  Longer Dialysis Sessions Improve Cardiac Systolic Function by Reducing Myocardial Stunning.. J Card Fail. 26(11), 1026-1027.
Saratzis, A., Bath M. F., Harrison S., Sayers R. D., Mahmood A., Sarafidis P., et al. (2015).  Long-Term Renal Function after Endovascular Aneurysm Repair.. Clin J Am Soc Nephrol. 10(11), 1930-6.
Loutradis, C., Papadopoulos C. E., Sachpekidis V., Ekart R., Krunic B., Karpetas A., et al. (2020).  Lung Ultrasound-Guided Dry Weight Assessment and Echocardiographic Measures in Hypertensive Hemodialysis Patients: A Randomized Controlled Study.. Am J Kidney Dis. 75(1), 11-20.
Potpara, T. S., Ferro C., Lip G. Y. H., Dan G. A., Lenarczyk R., Mallamaci F., et al. (2020).  Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based su. Europace. 22(3), 496-505.
Schoina, M., Loutradis C., Memmos E., Dimitroulas T., Pagkopoulou E., Doumas M., et al. (2020).  Microcirculatory function deteriorates with advancing stages of chronic kidney disease independently of arterial stiffness and atherosclerosis.. Hypertens Res.
Loutradis, C., Bikos A., Raptis V., Afkou Z., Tzanis G., Pyrgidis N., et al. (2019).  Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension.. Hypertens Res. 42(7), 1001-1010.
Sarafidis, P., Bowes E., Rumjon A., Ansari B., & Cairns H. (2013).  A novel technique for repositioning, under local anesthetic, malfunctioning and migrated peritoneal dialysis catheters.. Perit Dial Int. 33(6), 700-4.
Papadopoulou, E., Angeloudi E., Karras S., & Sarafidis P. (2018).  The optimal blood pressure target in diabetes mellitus: a quest coming to an end?. J Hum Hypertens. 32(10), 641-650.
Loutradis, C., & Sarafidis P. (2020).  Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease.. Expert Opin Pharmacother. 21(10), 1201-1217.
Schoina, M., Loutradis C., Theodorakopoulou M., Dimitroulas T., Triantafillidou E., Doumas M., et al. (2020).  The presence of diabetes mellitus further impairs structural and functional capillary density in patients with chronic kidney disease.. Microcirculation. e12665.
Van der Niepen, P., Rossignol P., Lengelé J-P., Berra E., Sarafidis P., & Persu A. (2017).  Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?. Curr Hypertens Rep. 19(1), 5.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές